Breaking News Instant updates and real-time market news.

BDRBF

Bombardier

$0.00

(0.00%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07

Bombardier cuts FY19 revenue view to about $17B, consensus $16.26B

Consolidated revenue guidance now expected to be ~$1.0B lower at ~$17.0B, representing ~10% growth year over year, excluding currency effects and divestitures. Previously, the company forecast FY19 revenue of $18B "or more." Other updated guidance: Aerospace businesses on track; Consolidated revenue guidance changed mainly due to revised Transportation outlook. Consolidated adjusted EBITDA expectations reduced from $1.65-1.80B to $1.50-1.65B, representing a ~20% increase year over year. Consolidated adjusted EBIT expectations reduced from $1.15-1.25B to $1.0-1.15B. Consolidated free cash flow guidance remains unchanged at breakeven +/-$250M. Business Aircraft still expected to deliver 150-155 aircraft; Commercial Aircraft deliveries now expected to be 30 vs 35 aircraft as the sale of the Q400 is now anticipated to close mid-year. Transportation revenue expectations revised from ~$9.5B to ~$8.75B, and adjusted EBIT margin from ~9% to ~8%.

  • 02

    May

  • 14

    May

  • 05

    Jun

BDRBF Bombardier
$0.00

(0.00%)

08/15/18
UBSW
08/15/18
INITIATION
Target $5
UBSW
Neutral
Bombardier initiated with a Neutral at UBS
UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Bombardier with a Neutral rating and $5 price target.
10/24/18
GSCO
10/24/18
DOWNGRADE
GSCO
Buy
Bombardier downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Noah Poponak removed Bombardier from his firm's Conviction List but keeps a Buy rating on the shares. The analyst says that with the equity market assigning a higher risk premium to cyclical end markets and balance sheet leverage, he no longer views Bombardier as a top pick across Industrials on a total risk/reward basis. He has a C$4.90 price target for the shares.
10/25/18
TDSI
10/25/18
UPGRADE
TDSI
Speculative Buy
Bombardier upgraded to Speculative Buy from Hold at TD Securities
02/15/19
UBSW
02/15/19
UPGRADE
UBSW
Buy
Bombardier upgraded to Buy from Neutral at UBS
UBS analyst Myles Walton upgraded Bombardier to Buy and raised his price target for the shares to C$3.80 from C$2.90. The post-earnings stock rally "was more a reaction to the absence of a big negative than anything particularly positive," Walton tells investors in a research note. He thinks this theme could continue through 2019 and finds the stock's current valuation as favorable.

TODAY'S FREE FLY STORIES

07:45
06/26/19
06/26
07:45
06/26/19
07:45
General news
U.S. MBA reported mortgage applications bounced 1.3% »

U.S. MBA reported…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

, FVRR

Fiverr

$29.00

-0.2 (-0.68%)

07:44
06/26/19
06/26
07:44
06/26/19
07:44
Upgrade
Upwork, Fiverr rating change  »

Upwork upgraded to Buy…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

FVRR

Fiverr

$29.00

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LINX

Linx S.A.

$0.00

(0.00%)

07:41
06/26/19
06/26
07:41
06/26/19
07:41
Syndicate
Linx S.A. 32.8M share IPO priced at $9.40 »

We are told the official…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

07:40
06/26/19
06/26
07:40
06/26/19
07:40
General news
Treasury Market Outlook: Treasury yields jumped higher »

Treasury Market Outlook:…

BBRX

Braeburn Pharmaceuticals

$0.00

(0.00%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Braeburn Pharmaceuticals initiated  »

Braeburn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$90.27

-0.53 (-0.58%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Upgrade
Fiserv rating change  »

Fiserv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVSI

Envision Solar

$5.11

-0.22 (-4.13%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Envision Solar initiated  »

Envision Solar initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$1.66

-0.05 (-2.93%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Initiation
Kadmon initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$57.44

-0.58 (-1.00%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Hot Stocks
Novocure announces publication of IQWiG rapid report for Optune »

Novocure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTR

CapStar Financial

$15.01

0.05 (0.33%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Downgrade
CapStar Financial rating change  »

CapStar Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCRX

Pacira

$43.53

0.39 (0.90%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Hot Stocks
Pacira says results show EXPAREL associated with 'significantly less' opioid use »

Pacira BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODT

Odonate Therapeutics

$28.14

-0.29 (-1.02%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Syndicate
Odonate Therapeutics 4.75M share Spot Secondary priced at $26.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 26

    Jun

X

U.S. Steel

$14.93

0.48 (3.32%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGO

Eldorado Gold

$5.46

-0.02 (-0.36%)

07:34
06/26/19
06/26
07:34
06/26/19
07:34
Upgrade
Eldorado Gold rating change  »

Eldorado Gold upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XON

Intrexon

$7.34

0.17 (2.37%)

07:33
06/26/19
06/26
07:33
06/26/19
07:33
Hot Stocks
Intrexon doses first patient in Phase 1/1b study of Acute Myeloid Leukemia drug »

Intrexon's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOSC

B.O.S. Better Online

$2.73

(0.00%)

07:33
06/26/19
06/26
07:33
06/26/19
07:33
Hot Stocks
B.O.S. Better Online receives $870,000 order for robotic system »

B.O.S Better Online…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRIM

Primoris

$19.57

0.32 (1.66%)

07:32
06/26/19
06/26
07:32
06/26/19
07:32
Hot Stocks
Primoris announces heavy civil award valued over $24M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$133.43

-4.37 (-3.17%)

, AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

07:31
06/26/19
06/26
07:31
06/26/19
07:31
Recommendations
Microsoft, Amazon.com, Oracle analyst commentary at Wedbush »

Pentagon JEDI contract to…

MSFT

Microsoft

$133.43

-4.37 (-3.17%)

AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

ORCL

Oracle

$56.07

-0.65 (-1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

EXTR

Extreme Networks

$5.73

0.08 (1.42%)

07:30
06/26/19
06/26
07:30
06/26/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

DNLI

Denali Therapeutics

$20.22

0.56 (2.85%)

07:29
06/26/19
06/26
07:29
06/26/19
07:29
Initiation
Denali Therapeutics initiated  »

Denali Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRCM

Care.com

$14.13

0.21 (1.51%)

07:28
06/26/19
06/26
07:28
06/26/19
07:28
Recommendations
Care.com analyst commentary  »

Care.com CFO resignation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRCM

Care.com

$14.13

0.21 (1.51%)

07:28
06/26/19
06/26
07:28
06/26/19
07:28
Downgrade
Care.com rating change  »

Care.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$48.24

-3.17 (-6.17%)

07:27
06/26/19
06/26
07:27
06/26/19
07:27
Recommendations
Lennar analyst commentary  »

Lennar selloff appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

MU

Micron

$32.71

-0.47 (-1.42%)

07:27
06/26/19
06/26
07:27
06/26/19
07:27
Upgrade
Micron rating change  »

Micron upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

AVAV

AeroVironment

07:27
06/26/19
06/26
07:27
06/26/19
07:27
Recommendations
AeroVironment analyst commentary  »

AeroVironment price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.